Upperton Pharma Solutions
Paul Kelsall possesses extensive experience in the pharmaceutical and manufacturing sectors. Currently serving as the Director of Clinical Manufacturing at Upperton Pharma Solutions since August 2018, Paul has previously held key positions such as General Manager at Okanagan Hockey UK Academy, Site Director at Aesica Pharmaceuticals Ltd, and Head of Compounding and Medical Devices at Nova Laboratories Limited. Paul's career also includes experience as Production Operations Leader at RECKITT BENCKISER and various roles at RECKITT BENCKISER / Boots Manufacturing, where responsibilities included Lean Six Sigma coaching and production management.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.